外匯新聞

Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors

Oncology company Mirati Therapeutics, Inc. (MRTX) and biopharmaceutical company Aadi Bioscience, Inc. (AADI) announced Wednesday a clinical collaboration to evaluate the combination of adagrasib, a KRASG12C selective inhibitor, and nab-sirolimus, a small molecule mTOR inhibitor complexed with human albumin in KRAS G12C mutant non-small cell lung cancer (NSCLC) and other solid tumors.

RTTNews | 951天前

KnowBe4 To Be Taken Private By Vista Equity Partners In All-cash Deal Valued At About $4.6 Bln

KnowBe4, Inc. (KNBE) announced Wednesday that it has entered into a definitive agreement to be acquired by Vista Equity Partners in an all-cash transaction valued at approximately $4.6 billion on an equity value basis.

RTTNews | 951天前

Best Buy's 48-hour Flash Sale Ends Today

Best Buy Co., Inc.'s flash sale ahead of the upcoming holiday season is live now with hundreds of deals on electronic items and games. The company's 48-hour Flash Sale that began on Tuesday, October 11 and ends today claims to be offering hefty savings on various tech products, like TVs, headphones, smartphones and more.

RTTNews | 951天前

Bay Street Seen Opening Higher

Higher Canadian and U.S. futures and firm crude oil prices point to a positive start for the Canadian market Wednesday morning.

RTTNews | 951天前

Merck Says Health Canada Granted Approval For KEYTRUDA To Treat Renal Cell Carcinoma

Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, announced Wednesday that Health Canada has granted approval for KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the adjuvant treatment of adults with renal cell carcinoma (RCC) at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.

RTTNews | 951天前

Owens & Minor Slashes FY22 Outlook; Stock Down 17%

Healthcare solutions company Owens & Minor, Inc. (OMI) on Wednesday preliminary results for the third quarter and slashed its adjusted earnings guidance for the full-year 2022.

RTTNews | 951天前

PepsiCo Lifts FY22 View As Q3 Results Top Estimates

Snack and beverage giant PepsiCo Inc. on Wednesday lifted its fiscal 2022 core earnings per share forecast above market estimates, as well as organic revenue growth view after reporting higher third-quarter results. Both earnings and top line beat Wall Street view. In pre-market activity on Nasdaq, Pepsi shares were gaining around 2.7 percent to trade at $166.96.

RTTNews | 951天前

more news

Sensex, Nifty Snap Three-day Losing Streak; PSU Stocks Lead Gains

Indian shares rose notably on Wednesday after three days of losses on worries about slowing global growth and the impact of rising interest rates on corporate profits.

RTTNews | 951天前

European Shares Rise Amid Mixed Earnings, Data

European stocks traded mostly higher on Wednesday as investors reacted to mixed earnings and regional data.

RTTNews | 952天前

FTSE Edges Higher Despite Weak GDP Data

U.K. stocks rose on Wednesday as investors reacted to mixed signals from the Bank of England on bond purchases.

RTTNews | 952天前

TikTok Plans To Operate E-commerce Fulfillment System In US

Social media app TikTok plans to operate U.S warehouses and product fulfillment centers to create its own e-commerce supply chain system, job listings on its website and LinkedIn indicate. TikTok reportedly began piloting a shopping feature last year in the U.S., Canada and the U.K. through a deal with Shopify.

RTTNews | 952天前